A New Hope for Bile Duct Cancer Patients
The TOPAZ-1 trial, a major study, has been tracking the effects of a combination treatment on patients with advanced bile duct cancer. This treatment pairs durvalumab with a mix of gemcitabine and cisplatin. The initial results were promising, showing that this combo could extend the lives of those